Replies to post #5841 on Halozyme Therapeutics Inc (HALO)

[maumar]

That royalties will be slightly down in spite of some contribution from SC Darzalex is also a bit unsettling. We had about $17M in Q3 and Q4 in 2017, I believe. It's pretty disappointing that we may go even lower than that three years later.

And yet, as you say, the stock is acting pretty well.